Xtl Biopharmaceuticals (XTLB) Inventory Average (2012 - 2014)
Xtl Biopharmaceuticals (XTLB) posted quarterly Inventory Average of $261500.0 for Q3 2014, down 22.4% year-on-year from $337000.0 in Q3 2013, and up 2.75% on a QoQ basis from $254500.0 in Q2 2014.
Xtl Biopharmaceuticals (XTLB) Inventory Average (2012 - 2014) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Inventory Average for 3 consecutive years, with $261500.0 the latest figure, recorded in Q3 2014.
- Quarterly Inventory Average fell 22.4% year-over-year to $261500.0 in Q3 2014, while the trailing twelve-month figure through Sep 2014 was $261500.0 (down 22.4% YoY) and the FY2013 annual result came in at $265500.0, changed N/A from the prior year.
- Inventory Average advanced to $261500.0 in Q3 2014 per XTLB's latest filing, from $254500.0 in the prior quarter.
- Over the last five years, Inventory Average for XTLB reached as high as $355500.0 in Q4 2013 and fell as low as $169000.0 in Q3 2012.
- A 3-year average of $265888.9 and a median of $261500.0 in 2014 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2013 — Inventory Average soared 99.41% — and 2014, when it retreated 22.4%.
- Year by year, Inventory Average stood at $190500.0 in 2012, then jumped by 86.61% to $355500.0 in 2013, then decreased by 26.44% to $261500.0 in 2014.
- According to Business Quant data, Inventory Average over the past three periods registered $261500.0, $254500.0, and $255000.0 for Q3 2014, Q2 2014, and Q1 2014 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 644.91 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.58 Bn | 2.58 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 261,500.00 |
| Jun 30, 2014 | 254,500.00 |
| Mar 31, 2014 | 255,000.00 |
| Dec 31, 2013 | 355,500.00 |
| Sep 30, 2013 | 337,000.00 |
| Jun 30, 2013 | 294,000.00 |
| Mar 31, 2013 | 276,000.00 |
| Dec 31, 2012 | 190,500.00 |
| Sep 30, 2012 | 169,000.00 |